At ESMO 2026, LACOG shares research across cancer types and strengthens international scientific collaboration. Dr. Gustavo Verusky highlights the group's participation and commitment to advancing cancer research in Latin America.
#LACOG #ESMO2026
24 views · 0 likes · 0 reposts · 0 replies
Symbiotic-GYN-18 (GOG-3145/ENGOT-EN37/APGOT-EN6/LACOG 0426-EVA): Phase 3 study of PF-08634456 in combination with pembrolizumab versus placebo plus pembrolizumab in participants with advanced or recurrent endometrial cancer
https://esmocongress.esmo.orgGenomic biomarkers of response to extreme bipolar androgen therapy (BAT) alternating darolutamide in metastatic castration-resistant prostate cancer: An ancillary biomarker analysis of the ExBAT/LACOG 0620 trial
https://esmocongress.esmo.orgSource: LACOG - Latin American Cooperative Oncology Group · x.com
